The creation of retatrutide, a novel dual stimulant targeting both GLP-1 and GIP receptors, involves a complex several-stage chemical process. Preliminary routes focused on protein fragment coupling, utilizing solid-phase synthesis methodologies to build the long peptide sequence. Subsequent study has explored alternative approaches, including enzy